Multiparameter Patient Monitoring Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Summary
GlobalData's Medical Devices sector report, “Multiparameter Patient Monitoring Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Multiparameter Patient Monitoring pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Multiparameter Patient Monitoring includes devices used for continuous monitoring of physiological and vital parameters such as, temperature, blood pressure (BP), oxygen saturation in blood (SpO2), respiration rate (RR) and capnography (CO2) in patients on a continuous basis.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Multiparameter Patient Monitoring under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Multiparameter Patient Monitoring and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Multiparameter Patient Monitoring under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Multiparameter Patient Monitoring Overview
4 Products under Development
4.1 Multiparameter Patient Monitoring - Pipeline Products by Stage of Development
4.2 Multiparameter Patient Monitoring - Pipeline Products by Segment
4.3 Multiparameter Patient Monitoring - Pipeline Products by Territory
4.4 Multiparameter Patient Monitoring - Pipeline Products by Regulatory Path
4.5 Multiparameter Patient Monitoring - Pipeline Products by Estimated Approval Date
7.63 Jan 30, 2023: Philips to lay off 6,000 employees in drive to improve profitability
7.64 Jan 30, 2023: GE HealthCare Reports Fourth Quarter and Full Year 2022 Financial Results
7.65 Jan 30, 2023: Jana Care to Enter Collaboration with Roche to Develop and Distribute Blood Testing Platform to Improve Remote Care for Patients With Chronic Kidney and Heart Disease
7.66 Jan 30, 2023: Intel warns officials it plans 343 layoffs at its Folsom campus
7.67 Jan 27, 2023: Intel Reports Fourth-Quarter and Full-Year 2022 Financial Results
7.68 Jan 26, 2023: OSI Systems announces fiscal 2023 Q2 results
7.69 Jan 24, 2023: Intel Layoff Hundreds of Jobs
7.7 Jan 23, 2023: Intel hires Frank Yeary as independent chair
7.71 Jan 23, 2023: Intel Chairman Omar Ishrak steps down